Agilent | A - Cash And Equivalent

Stock Price
116.93
Daily Change
1.38 1.19%
Monthly
4.39%
Yearly
9.41%
Q2 Forecast
113.08

Agilent reported $1.76B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Abbott USD 8.52B 1.01B Dec/2025
Agilent USD 1.76B 31M Dec/2025
Align Technology USD 1B 103.43M Sep/2025
Bio Techne USD 172.88M 27.92M Dec/2025
Bio-Rad Laboratories USD 529.8M 134M Dec/2025
Bruker USD 293.1M 201.1M Sep/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Danaher USD 5.7B 1.09B Mar/2026
Dentsply International USD 326M 37M Dec/2025
Edwards Lifesciences USD 2.4B 538M Mar/2026
Henry Schein USD 136M 9M Sep/2025
Illumina USD 1.42B 368M Dec/2025
Intuitive Surgical USD 7.98B 1.05B Mar/2026
IQVIA Holdings USD 1.98B 166M Dec/2025
Laboratory Of America USD 532.3M 65.8M Dec/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Myriad Genetics USD 149.6M 4.2M Dec/2025
OraSure Technologies USD 199.28M 17.2M Dec/2025
Quest Diagnostics USD 393M 27M Mar/2026
Quidel USD 169.8M 71.7M Dec/2025
Repligen USD 566.02M 182.73M Dec/2025
Revvity USD 919.86M 11.53M Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Waters USD 587.83M 128.71M Dec/2025
Zimmer Biomet Holdings USD 591.9M 700.8M Dec/2025